Magnetic resonance high intensity focused ultrasound

DEVICE2 trials

Sponsors

AeRang Kim

Conditions

Desmoid TumorEwing SarcomaGerm Cell TumorGerm Cell TumorsHepatic TumorNeuroblastomaOsteosarcomaPediatric Cancer

Phase 1

MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors

CompletedNCT02076906

AeRang KimDesmoid Tumor, Ewing Sarcoma, Germ Cell Tumor +7

Start: 2014-04-30End: 2024-11-24Updated: 2025-01-01

A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors

TerminatedNCT02536183

AeRang KimEwing Sarcoma, Germ Cell Tumors, Hepatic Tumor +7

Start: 2016-10-31End: 2022-10-31Updated: 2023-08-29

Related Papers

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.

2018-07-11150 citations

Phase 1 trial of lyso-thermosensitive liposomal doxorubicin (LTLD) and magnetic resonance guided high intensity focused ultrasound (MR-HIFU) for pediatric refractory solid tumors.

Journal of Clinical Oncology2017-05-208 citations

Safety and feasibility of magnetic resonance-guided high intensity focused ultrasound (MR-HIFU) for the ablation of relapsed or refractory pediatric solid tumors.

Journal of Clinical Oncology2016-05-20